A robust screening method for dietary agents that activate tumour-suppressor microRNAs

Area of Science:

• Oncology
• Molecular Biology
• Natural Product Chemistry

Background:

• Dietary agents, including natural products, show potential anti-cancer effects, but their mechanisms are often unclear.
• Resveratrol has demonstrated anti-cancer properties by upregulating tumor-suppressor microRNAs (miRNAs).
• Identifying novel natural compounds that activate tumor-suppressor miRNAs is crucial for developing new cancer therapies.

Purpose of the Study:

• To discover new dietary products capable of activating tumor-suppressor miRNAs for cancer prevention and treatment.
• To develop and utilize a novel screening system for identifying miRNA-activating natural compounds.
• To elucidate the molecular mechanisms underlying the anti-cancer effects of these natural compounds.

Main Methods:

• Development of a luciferase-based reporter system to monitor miR-200c tumor-suppressor activity.
• Screening of a library of 139 natural substances for their ability to induce miR-200c expression.
• In vitro assays to assess the impact of identified compounds on breast cancer cell invasiveness.
• Analysis of the molecular pathway involving miR-200c, ZEB1, and E-cadherin.

Main Results:

• Three natural compounds—enoxolone, magnolol, and palmatine chloride—were identified as potent inducers of miR-200c expression in breast cancer cells at 10 μM.
• These compounds significantly suppressed the invasiveness of breast cancer cells in vitro.
• The study confirmed that increased miR-200c expression, induced by these natural substances, leads to the inhibition of ZEB1 and the induction of E-cadherin.

Conclusions:

• The developed screening system is effective for rapidly identifying natural molecules with tumor-suppressor activity via miRNA activation.
• Enoxolone, magnolol, and palmatine chloride show promise as novel therapeutic agents for human cancers.
• These findings provide a mechanistic link between natural compounds, miRNA regulation, and cancer cell behavior, highlighting potential for targeted therapies.